Location: Home
  • search
  • go
  • Relate News
  • 1/6/2023CDE Solicits Comments on Draft Implementation Proposal and Chinese Tra...
  • 1/6/2023CDE Seeks Comments on Draft Chinese Translation of ICH Guidelines M11
  • 1/6/2023China Issues Two New Policies on BMI Reimbursement of Covid Hospitaliz...
  • 1/6/2023Latest Cancer Drugmaker's IPO Mints China's Latest Billionaire
  • 1/6/2023Recent Executive Moves
  • 1/6/2023Drug R&D and Product Registration News Digest January 2023 (1)
  • 1/5/2023GSK and WuXi Biologics Enter License Deal on Multiple Novel Bi- & Mult...
  • 1/5/2023CANbridge Consolidates Gene Therapy Portfolio by Exercising License Op...
  • 1/5/2023NMPA Holds National Drug Regulatory Conference in Beijing
  • 1/5/20232022 NRDL Access Negotiation Reinitiated with Industry Hoping for "Mod...
  • 1/5/2023Adcendo ApS Announces License Agreement with Duality Biologics on Next...
  • 1/5/2023Aurisco to Build Oligonucleotides Manufacturing Facility in China
  • 1/5/2023Shionogi Covid Drug Xocova May Get Chinese Approval in March
  • 1/5/202320 Promising New Drugs Anticipated To Be Approved in China 2023 (Pharm...
  • 1/5/2023FDA's Wang Yaning: Anti-Aβ Therapies Can Delay Progression of AD (Pha...
  • 1/4/2023Biocytogen and Hansoh Pharma Enter Antibody License Deal for China
  • 1/4/2023NHC and SATCM Announce Action Plan for the Overall Pain Management Tri...
  • 1/3/2023Fosun Pharma and Henlius Entered into an Exclusive License Agreement f...
  • 1/3/2023CDE Solicits Comments on the Technical Guidelines for R&D of Oral Comp...
  • 1/3/2023China Turns Down EU Offer of Free COVID Vaccines
  • 1/3/2023Legend Biotech's NDA for Ciltacabtagene Autoleucel (Cilta-Cel) Accepte...
  • 12/30/2022Merck's COVID Drug Molnupiravir Conditionally Approved in China
  • 12/30/2022CDE Publicizes the List of Reference Formulations for GQCE Studies (65...
  • 12/30/2022NHC Issues the Clinical Guidelines for New Antitumor Drugs (2022 Editi...
  • 12/30/2022CNIPA and NHSA Issues Joint Policy on Strengthening IP Protection in C...
  • 12/30/2022Abbott to Exit China's Pediatric Nutrition Market
  • 12/30/2022Drug R&D and Product Registration News Digest December 2022 (4)
  • 12/30/2022Recent Executive Moves
  • 12/30/2022Financial-related Company News Digest (December 2022)
  • 12/30/2022Covid Policy U-Turn Puts China in Disarray with Pharma in the Front Ro...
  • Page:60/719 Total number of articles:21546: [First][<<] [58] [59] [60] [61] [62] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group